{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:43Z","timestamp":1786991323226,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaip.2024.05.019","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T22:08:09Z","timestamp":1716242889000},"page":"2372-2380.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study"],"prefix":"10.1016","volume":"12","author":[{"given":"John","family":"Oppenheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib A.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Philippe","family":"Boulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A.","family":"Hanania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kerwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Peachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Pizzichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agne","family":"Zarankaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.05.019_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1155\/2005\/837645","article-title":"A\u00a0systematic review of risk factors associated with near-fatal and fatal asthma","volume":"12","author":"Alvarez","year":"2005","journal-title":"Can Respir J"},{"key":"10.1016\/j.jaip.2024.05.019_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41533-020-0164-4","article-title":"Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan","volume":"30","author":"Chang","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52361-9","article-title":"Effect of asthma control on general health-related quality of life in patients diagnosed with adult-onset asthma","volume":"9","author":"Ilmarinen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.05.019_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3132\/pcrj.2007.00002","article-title":"The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK","volume":"16","author":"Lloyd","year":"2007","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2024.05.019_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaip.2014.02.011","article-title":"Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma","volume":"2","author":"Luskin","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.019_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.05.00037905","article-title":"Risk factors of frequent exacerbations in difficult-to-treat asthma","volume":"26","author":"ten Brinke","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.05.019_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/resp.12642","article-title":"COPD and its comorbidities: impact, measurement and mechanisms","volume":"20","author":"Negewo","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2024.05.019_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1378\/chest.121.2.329","article-title":"The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea","volume":"121","author":"Magadle","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2024.05.019_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-017-0422-6","article-title":"Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care","volume":"17","author":"Guti\u00e9rrez","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/02770903.2013.787624","article-title":"Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma","volume":"50","author":"Lane","year":"2013","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2024.05.019_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.rmed.2015.01.012","article-title":"Defining moderate asthma exacerbations in clinical trials based on ATS\/ERS joint statement","volume":"109","author":"Virchow","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.05.019_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s41687-021-00338-6","article-title":"Measuring respiratory symptoms in moderate\/severe asthma: evaluation of a respiratory symptom tool, the E-RS(R): COPD in asthma populations","volume":"5","author":"Tabberer","year":"2021","journal-title":"J\u00a0Patient Rep Outcomes"},{"key":"10.1016\/j.jaip.2024.05.019_bib18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJMoa1714257","article-title":"Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations","volume":"378","author":"McKeever","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41687-020-00274-x","article-title":"The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data","volume":"5","author":"Briggs","year":"2021","journal-title":"J\u00a0Patient Rep Outcomes"},{"key":"10.1016\/j.jaip.2024.05.019_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1164\/ajrccm.160.2.9811100","article-title":"Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group","volume":"160","author":"Tattersfield","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1164\/ajrccm.158.3.9802069","article-title":"Potential masking effects of salmeterol on airway inflammation in asthma","volume":"158","author":"McIvor","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-6-13","article-title":"Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study","volume":"6","author":"Partridge","year":"2006","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S2213-2600(21)00004-7","article-title":"The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study","volume":"9","author":"McDowell","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1183\/09031936.06.00137704","article-title":"Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations","volume":"27","author":"Jayaram","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.05.019_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.anai.2023.10.009","article-title":"At-home asthma mortality unchanged despite declining mortality in other settings: US death certificate data (2000\u20132019)","volume":"132","author":"Kilpatrick","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.05.019_bib27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib28","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.05.019_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.05.019_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824005336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824005336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:28:08Z","timestamp":1730521688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824005336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213219824005336"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.05.019","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}